平板探测器

Search documents
康众医疗: 康众医疗2025年半年度募集资金存放与使用情况的专项报告
Zheng Quan Zhi Xing· 2025-08-22 16:49
| 期 | 效益 | 效益 | (2)- | 有) | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | (1) | 化 | 平板探测器生产 | | | | | | | | | | | | 21,386.66 | 21,386.66 | 21,386.66 | 1,778.45 | 12,527.92 | - 8,858.74 | 58.58 | 2025 年 | 12 月 | 无 | 不适用 | 不适用 | 否 | | 基地建设项目 | 研发服务中心建 | | | | | | | | | | | | | 10,190.09 | 10,190.09 | 10,190.09 | 370.94 | 5,480.92 | - 4,709.17 | 53.79 | 2025 年 | 12 月 | 无 | 不适用 | 不适用 | 否 | | 设项目 | 补充流动资金项 | | | | | | | | | | | | | 13,000.00 | 13,000.00 | 13,0 ...
奕瑞科技收盘上涨1.47%,滚动市盈率38.27倍,总市值179.47亿元
Sou Hu Cai Jing· 2025-05-08 11:26
Group 1 - The core viewpoint of the news highlights the performance and market position of Yirui Technology, noting its current stock price, market capitalization, and PE ratio compared to industry averages [1] - As of March 31, 2025, Yirui Technology has 5,745 shareholders, a decrease of 883 from the previous period, with an average holding value of 352,800 yuan and an average holding quantity of 27,600 shares [1] - The company specializes in the research, production, sales, and service of digital X-ray detectors, high-voltage generators, and other core components, having mastered four major sensor technologies [1] Group 2 - In the latest quarterly report for Q1 2025, Yirui Technology achieved a revenue of 482 million yuan, a year-on-year decrease of 1.92%, while net profit was 143 million yuan, an increase of 2.74%, with a gross profit margin of 48.92% [1] - The company's rolling PE ratio is 38.27, which is lower than the industry average of 49.20 and the industry median of 36.56, ranking 77th in the industry [2] - The industry average PE ratio is 49.20, with a median of 36.56, indicating that Yirui Technology is positioned below the average in terms of valuation metrics [2]
奕瑞科技(688301):科创板公司动态研究:主业筑底企稳,新技术百花齐放
Guohai Securities· 2025-05-05 15:18
Investment Rating - The report assigns a "Buy" rating for the company, marking its first coverage [1][6][7]. Core Insights - The company's main business is stabilizing, with new technologies flourishing, as evidenced by the launch of various innovative products in the medical and industrial sectors [3][4]. - The company reported a revenue of 1.831 billion yuan in 2024, a slight decrease of 1.74% year-on-year, with a net profit of 465 million yuan, down 23.43% year-on-year [3]. - The company is actively expanding its product matrix and has made significant advancements in the development of new core components and X-ray comprehensive solutions [4][6]. Financial Performance Summary - In 2024, the company achieved a revenue of 1.831 billion yuan, with a gross margin of 50.11% and a net margin of 24.59% [3]. - For Q1 2025, the company reported a revenue of 482 million yuan, a year-on-year decrease of 1.92%, but a net profit increase of 2.74% to 143 million yuan [3]. - The company forecasts revenues of 2.162 billion yuan in 2025, with a projected net profit of 574 million yuan, reflecting a growth rate of 18% and 23% respectively [5][6]. Product Development and Market Position - The company has successfully launched several new products, including high-resolution detectors and various X-ray sources, enhancing its competitive edge in the market [3][4]. - The company is focusing on R&D investments in CMOS detectors, CT detectors, and photon counting detectors, which are expected to drive future growth [3][4]. - The company aims to strengthen its position as a core supplier of digital X-ray components and comprehensive solutions through continuous innovation and global business expansion [6].